Cullinan Therapeutics
CGEM
#6903
Rank
โ‚น37.06 B
Marketcap
โ‚น633.42
Share price
-1.07%
Change (1 day)
-54.51%
Change (1 year)

Cullinan Therapeutics (CGEM) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น34.10 Billion

According to Cullinan Therapeutics's latest financial reports the company has โ‚น34.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cullinan Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น34.22 B-11.97%
2023-12-31โ‚น38.88 B0.55%
2022-12-31โ‚น38.66 B78.86%
2021-12-31โ‚น21.61 B40.63%
2020-12-31โ‚น15.37 B118.57%
2019-12-31โ‚น7.03 B197.32%
2018-12-31โ‚น2.36 B